ストックスクリーナーアプリを入手
23.82
5.87%
1.32
プレマーケット:
23.31
-0.51
-2.14%
前日終値:
$22.50
開ける：
$22.62
24時間の取引高:
141.15K
Relative Volume:
0.87
時価総額：
$655.07M
収益：
-
当期純損益:
$-69.47M
株価収益率:
-4.2556
EPS:
-5.5973
ネットキャッシュフロー:
$-73.92M
1週間 パフォーマンス:
+6.53%
1か月 パフォーマンス:
-27.00%
6か月 パフォーマンス:
+11.05%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$22.62
$24.29
1週間の範囲:
$21.34
$24.29
52週間の値動き範囲:
$14.42
$38.93
Lenz Therapeutics Inc Stock (LENZ) Company Profile
名前
Lenz Therapeutics Inc
セクター
電話
858-925-7000
住所
201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH
LENZ を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LENZ
Lenz Therapeutics Inc
|
23.82 | 655.07M | 0 | -69.47M | -73.92M | -5.5973 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Lenz Therapeutics Inc Stock (LENZ) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-09-27 | 開始されました | Raymond James | Outperform |
| 2024-08-12 | 開始されました | H.C. Wainwright | Buy |
| 2024-04-15 | 開始されました | Leerink Partners | Outperform |
| 2024-04-15 | 開始されました | William Blair | Outperform |
| 2024-04-10 | 開始されました | Citigroup | Buy |
| 2024-03-27 | 開始されました | Piper Sandler | Overweight |
| 2023-02-23 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-02-23 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2023-02-23 | ダウングレード | Cowen | Outperform → Market Perform |
| 2023-01-25 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-01-18 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-01-06 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2023-01-06 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-15 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-06-17 | 開始されました | BMO Capital Markets | Outperform |
| 2022-04-14 | 開始されました | BTIG Research | Buy |
| 2022-03-22 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-02-18 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2021-07-20 | 開始されました | Morgan Stanley | Overweight |
| 2021-07-20 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Lenz Therapeutics Inc (LENZ) 最新ニュース
Lincoln Electric Holdings, Inc. (NASDAQ:LECO) Short Interest Down 5.0% in December - Defense World
LifeVantage Co. (NASDAQ:LFVN) Short Interest Down 5.4% in December - Defense World
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Sees Significant Increase in Short Interest - Defense World
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Sees Significant Increase in Short Interest - Defense World
Morgan Stanley Cuts U.S. Bancorp (NYSE:USB) Price Target to $59.00 - Defense World
Short Interest in LENZ Therapeutics, Inc. (NASDAQ:LENZ) Expands By 11.9% - MarketBeat
Barclays PLC Has $391,000 Stake in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - Defense World
Barclays PLC Buys 12,051 Shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ) - MarketBeat
LENZ Therapeutics (NASDAQ:LENZ) Trading Down 5%Time to Sell? - MarketBeat
Harbor Capital Advisors Inc. Buys Shares of 43,989 LENZ Therapeutics, Inc. (NASDAQ:LENZ) - MarketBeat
Brokerages Set LENZ Therapeutics, Inc. (NASDAQ:LENZ) PT at $35.40 - Defense World
Jane Street Group LLC Acquires Shares of 12,027 LENZ Therapeutics, Inc. (NASDAQ:LENZ) - Defense World
LENZ Therapeutics (NASDAQ:LENZ) Shares Down 8.9%Here's What Happened - MarketBeat
Intellia stock hurts gene editing after layoffs (NTLA:NASDAQ) - Seeking Alpha
Lenz Therapeutics New Becomes Oversold (LENZ) - Nasdaq
Financial Survey: Fresh Tracks Therapeutics (NASDAQ:FRTX) vs. LENZ Therapeutics (NASDAQ:LENZ) - Defense World
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Receives Average Rating of "Buy" from Brokerages - MarketBeat
SkyWater Technology, Inc. (NASDAQ:SKYT) Shares Purchased by Barclays PLC - Defense World
NI Holdings, Inc. (NASDAQ:NODK) Shares Purchased by Barclays PLC - Defense World
Barclays PLC Raises Stock Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - Defense World
Geode Capital Management LLC Lowers Stock Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - MarketBeat
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Shares Sold by Geode Capital Management LLC - Defense World
Companies Like LENZ Therapeutics (NASDAQ:LENZ) Are In A Position To Invest In Growth - Simply Wall St
LENZ Therapeutics (NASDAQ:LENZ) Trading Down 4.1%What's Next? - MarketBeat
State Street Corp Raises Stake in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - Defense World
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Shares Acquired by State Street Corp - MarketBeat
LENZ Therapeutics (NASDAQ:LENZ) Trading Up 6.3%Should You Buy? - MarketBeat
LENZ Therapeutics (NASDAQ:LENZ) Shares Down 4.1% – What’s Next? - Defense World
Wellington Management Group LLP Invests $585,000 in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - MarketBeat
LENZ Therapeutics (NASDAQ:LENZ) Shares Down 4.1%Time to Sell? - MarketBeat
BNP Paribas Financial Markets Has $63,000 Stock Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - Defense World
Presbyopia Therapeutics Market Size was highest in the US among the 7MM, was ~USD 8,039 million, and is expected to increase by 2034 | DelveInsight - Barchart
Presbyopia Therapeutics Market Size was highest in the US among - openPR
LENZ Therapeutics (NASDAQ:LENZ) Stock Price Up 5.8%Here's What Happened - MarketBeat
Brokerages Set LENZ Therapeutics, Inc. (NASDAQ:LENZ) Price Target at $35.40 - Defense World
Charles Schwab Investment Management Inc. Has $2.93 Million Stake in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - MarketBeat
Charles Schwab Investment Management Inc. Has $2.93 Million Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - Defense World
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Sotherly Hotels (NASDAQ:SOHOO) Shares Down 5% – Here’s What Happened - Defense World
XOMA (NASDAQ:XOMAP) Trading Down 0.6% – Should You Sell? - Defense World
Onfolio (NASDAQ:ONFO) Trading 1.1% Higher – Should You Buy? - Defense World
Sumco (OTCMKTS:SUMCF) Shares Up 2.4% – Still a Buy? - Defense World
Cizzle Biotechnology (LON:CIZ) Shares Down 5% – What’s Next? - Defense World
NeurAxis (NASDAQ:NRXS) Stock Price Down 5.3% – Here’s What Happened - Defense World
Glass House Brands (OTCMKTS:GLASF) Shares Up 1.3% – Here’s What Happened - Defense World
The Manufacturers Life Insurance Company Has $740,000 Stock Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Century Lithium (CVE:LCE) Trading Down 1.7% – Here’s What Happened - Defense World
Shaftesbury Capital (LON:SHC) Trading Down 1.4% – Here’s What Happened - Defense World
Short Interest in DatChat, Inc. (NASDAQ:DATS) Drops By 56.0% - Defense World
Metal Sky Star Acquisition (NASDAQ:MSSAU) Trading 1.6% Higher – Should You Buy? - Defense World
Indaptus Therapeutics (NASDAQ:INDP) Shares Down 1% – Here’s Why - Defense World
Lenz Therapeutics Inc (LENZ) 財務データ
収益
当期純利益
現金流量
EPS
Lenz Therapeutics Inc (LENZ) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Schimmelpennink Evert B. | President, CEO and Secretary |
Jul 22 '24 |
Option Exercise |
1.04 |
45,000 |
46,800 |
45,000 |
| Chevallard Daniel R. | Chief Financial Officer |
May 14 '24 |
Buy |
15.68 |
3,188 |
49,988 |
3,188 |
| MCCOLLUM JAMES W | Director |
May 13 '24 |
Buy |
15.99 |
31,332 |
501,093 |
525,565 |
| RA CAPITAL MANAGEMENT, L.P. | Director |
Mar 21 '24 |
Buy |
15.03 |
998,009 |
15,000,075 |
3,319,339 |
4.81%
大文字化:
|
ボリューム (24 時間):